From: CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection
Engerix-B
n = 19
Engerix B-CPG
N = 19
Male (n)
18
14
Prior Vaccine Failure (n)
10
9
Age (Mean ± SD)
42.9 ± 7.3
41.0 ± 7.4
CD4+ T cell count (Mean ± SD)
543 ± 228
647 ± 262
Proportion with HIV RNA <50 copies/mL
100%